Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Sensitivity of Self-Reported Opioid Use in Case-Control Studies: Healthy Individuals Versus Hospitalized Patients Publisher Pubmed



Rashidian H1 ; Hadji M2 ; Marzban M3 ; Gholipour M4 ; Rahimimovaghar A5 ; Kamangar F6 ; Malekzadeh R7 ; Weiderpass E8, 9, 10, 11 ; Rezaianzadeh A12 ; Moradi A4 ; Babhadiashar N5 ; Ghiasvand R13 ; Khavaridaneshvar H2 ; Haghdoost AA14 Show All Authors
Authors
  1. Rashidian H1
  2. Hadji M2
  3. Marzban M3
  4. Gholipour M4
  5. Rahimimovaghar A5
  6. Kamangar F6
  7. Malekzadeh R7
  8. Weiderpass E8, 9, 10, 11
  9. Rezaianzadeh A12
  10. Moradi A4
  11. Babhadiashar N5
  12. Ghiasvand R13
  13. Khavaridaneshvar H2
  14. Haghdoost AA14
  15. Zendehdel K2, 15
Show Affiliations
Authors Affiliations
  1. 1. Neuroscience Research Center, Institute of Neuropharmacology, Kerman University of Medical Sciences, Kerman, Iran
  2. 2. Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
  3. 3. Student’ Research Center Committee, Shiraz University of Medical Science, Shiraz, Iran
  4. 4. Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
  5. 5. Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran
  6. 6. Department of Public Health Analysis, School of Community Health and Policy, Morgan State University, Baltimore, MD, United States
  7. 7. Digestive Oncology Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
  8. 8. Department of Research, Cancer Registry of Norway, Institute of Population-Based Cancer Research, Oslo, Norway
  9. 9. Department of Community Medicine, Faculty of Health Sciences, University of Tromso, Arctic University of Norway, Tromso, Norway
  10. 10. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
  11. 11. Genetic Epidemiology Group, Folkhalsan Research Center, Helsinki, Finland
  12. 12. Colorectal Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
  13. 13. Oslo Centre for Biostatistics and Epidemiology, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway
  14. 14. Regional Knowledge Hub, WHO Collaborating Centre for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, Iran
  15. 15. Cancer Biology Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Source: PLoS ONE Published:2017


Abstract

Background: Several case-control studies have shown associations between the risk of different cancers and self-reported opium use. Inquiring into relatively sensitive issues, such as the history of drug use, is usually prone to information bias. However, in order to justify the findings of these types of studies, we have to quantify the level of such a negative bias. In current study, we aimed to evaluate sensitivity of self-reported opioid use and suggest suitable types of control groups for case-control studies on opioid use and the risk of cancer. Methods: In order to compare the validity of the self-reported opioid use, we cross-validated the response of two groups of subjects 1) 178 hospitalized patients and 2) 186 healthy individuals with the results of their tests using urine rapid drug screen (URDS) and thin layer chromatography (TLC). The questioners were asked by trained interviewers to maximize the validity of responses; healthy individuals were selected from the companions of patients in hospitals. Results: Self-reported regular opioid use was 36.5% in hospitalized patients 19.3% in healthy individuals (p-value> 0.001).The reported frequencies of opioid use in the past 72 hours were 21.4% and 11.8% in hospitalized patients and healthy individuals respectively. Comparing their responses with the results of urine tests showed a sensitivity of 77% and 69% among hospitalized patients and healthy individuals for self-reports (p-value = 0.4). Having corrected based on the mentioned sensitivities; the frequency of opioid regular use was 47% and 28% in hospitalized patients and healthy individuals, respectively. Regular opioid use among hospitalized patients was significantly higher than in healthy individuals (p-value> 0.001). Conclusion: Our findings showed that the level of opioid use under-reporting in hospitalized patients and healthy individuals was considerable but comparable. In addition, the frequency of regular opioid use among hospitalized patients was significantly higher than that in the general population. Altogether, it seems that, without corrections for these differences and biases, the results of many studies including case-control studies on opioid use might distort findings substantially. © 2017, Public Library of Science. All rights reserved. This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Other Related Docs
17. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study, Cancer Epidemiology Biomarkers and Prevention (2018)
27. Opium Abuse and Its Problems in Anesthesia Practice: A Review From Bench to Bedside, Journal of Cellular and Molecular Anesthesia (2016)
32. Validity of Self-Reported Substance Use: Research Setting Versus Primary Health Care Setting, Substance Abuse: Treatment# Prevention# and Policy (2021)
38. Opium Use and the Risk of Head and Neck Squamous Cell Carcinoma, International Journal of Cancer (2021)
41. Opium Addiction and Risk of Laryngeal and Esophageal Carcinoma, Iranian Journal of Otorhinolaryngology (2017)
48. Metabolomics Reveals Biomarkers of Opioid Use Disorder, Translational Psychiatry (2021)
50. Iran in Transition, The Lancet (2019)